On Aug. 10, AST GVT issued private health insurance amendments.
AST GVT registered Private health insurance (medical devices and human tissue products) amendment rules (no. 1) 2023, to update associated fees for assessments.
In addition, AST GVT also published an explanatory statement regarding the same.
Follows AST PRL Dec. 2022 modernizing private health insurance bills, see #155332.
These amendment rules amend Private health insurance (medical devices and human tissue products) rules (no. 1) 2023; namely, amends associated fees for assessments.
That is, associated fees for assessments required for listing and variation applications to list/vary an item on prescribed list of medical devices and human tissue products.
They also amend time for when associated cost-recovery fees become due, payable.
In addition, amendments correct inadvertent errors, decrease certain fees to align with those advised to industry in relevant cost recovery implementation statement (CRIS).
Effectiveness
These amendment rules commence on Sep. 1, 2023.
Sep. 2023 First Compilation Registered
On Sep. 13, 2023, AST GVT registered compilation no. 1 of Private health insurance (medical devices and human tissue products) rules (no. 1) 2023, setting out the text of the rules as amended as detailed above and in force on Sep. 1, 2023.
Oct. 2023 Instrument Registered
On Oct. 18, 2023, AST GVT registered the Private health insurance (medical devices and human tissue products) rules (no. 2) 2023, which commence on Nov. 1, 2023.
These rules update the list of the kinds of medical devices and human tissue products for which a benefit must be paid, where the listed item is provided as per the Private health insurance act 2007, and set out minimum benefit payable for each listed item.
Corrects errors in benefits and changes the condition on 37 billing codes in schedule.
Issued explanatory statement; AST GVT considered feedback from stakeholders in making amendments, i.e., from hospitals, private health insurers, and medical devices sponsors re the 37 codes, advice from sponsors of billing codes re incorrect benefits.
The whole of this amendment instrument commences on/from Nov. 11, 2023.
Replaces it with a new schedule, rectifies errors; sch 1 is known as prescribed list of medical devices and human tissue products; amendment takes effect Aug. 8, 2024.
The rules remake the rules registered on Jul. 30 above, to update the list of medical devices and human tissue products for which a benefit must be paid.
In accordance with section 2, the updated rules commence on Nov. 1, 2024.
Regulators
AST GVT
Entity Types
IB; Ins
Reference
Info, RF F2024L01355, 10/24/2024; RF F2024L00939, 7/30/2024; Info, RF F2023L01487, 11/10/2023; RF F2023L01399, 10/18/2023; RF F2023C00801, 9/13/2023; RF F2023L01073, 8/10/2023; Private health insurance (medical devices and human tissue products) rules (no. 2) 2023; Private health insurance (medical devices and human tissue products) amendment rules (no. 2) 2023; Private health insurance (medical devices and human tissue products) rules (no. 1) 2024; Private health insurance (medical devices and human tissue products) amendment (no. 2) rules 2024;
